The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype.
about
Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin.Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes.Genetic variants associated with warfarin dosage in Kuwaiti population.CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites.Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients.CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy.Genes affecting warfarin response-interactive or additive?The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation.Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study.
P2860
Q35161650-63FA9576-0BDA-4543-BCCF-8CFD71AE8E2BQ37325594-248E5DAF-D442-4EE8-AD0C-CBB2BDC7955BQ38734321-4BBF30D3-E87A-4914-BDE5-435B9A044E41Q38737797-DC6036B4-910B-4AA5-85F6-4AD02B3207FEQ38830008-BA7A164B-CD65-472D-A965-D0C6E684F131Q39267258-3D2D0AB1-FCCB-45A6-8F16-BE1D22B6EA3DQ41478624-57A6AF24-3F9D-48B9-BA1A-43372D42A12DQ42255919-CACDDE1C-B200-4C19-9D0D-FD0B4B36347CQ47137383-D93CF455-F36F-4D6C-9314-3D98520F9EF5Q48577324-CE083EB2-F6DB-4628-BD16-938D61D8792A
P2860
The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The pharmacokinetics and pharm ...... lationship to VKORC1 genotype.
@en
The pharmacokinetics and pharmacodynamics of single dose
@nl
type
label
The pharmacokinetics and pharm ...... lationship to VKORC1 genotype.
@en
The pharmacokinetics and pharmacodynamics of single dose
@nl
prefLabel
The pharmacokinetics and pharm ...... lationship to VKORC1 genotype.
@en
The pharmacokinetics and pharmacodynamics of single dose
@nl
P2093
P2860
P1476
The pharmacokinetics and pharm ...... lationship to VKORC1 genotype.
@en
P2093
Andrew A Somogyi
Berit P Jensen
Heather M James
John Maddison
Melanie Gentgall
Paul E Rolan
P2860
P304
P356
10.1111/J.1365-2125.2012.04335.X
P407
P577
2013-01-01T00:00:00Z